CAS 3382 63 6 Ezetimibe Intermediates Purity Not less 99.0% cGMP Standard

CAS : 3382-63-6 Ezetimibe intermediates Purity : Not Less than 99.0 % cGMP standard

Chemical Name : 4 - [ [ ( 4 - Fluorophenyl ) imino ] methyl ] - phenol

CAS No . : 3382-63-6

Synonym : 4 - [ [ ( 4 - Fluorophenyl ) imino ] methyl ] - phenol

Molecular Formula : C13H10FNO

Molecular Weight : 215.22

Usage : Ezetimibe Intermediates 

Description: Ezetimibe is the active pharmaceutical ingredient (API) of branded drug Zetia, or one of the active pharmaceutical ingredients (API) of branded drug Liptruzet (the other API is atorvastatin) or Vytorin (the other API is simivastatin). It was innovated by Schering-Plough Pharmaceuticals and co-marketed with Merck/MSD. Ezetimibe is used to reduce the amount of cholesterol and other fatty substances in the blood. It may be used alone or with other statins such as atorvastatin and simivastatin.

4 - [ [ ( 4 - Fluorophenyl ) imino ] methyl ] - phenol CAS No . : 3382-63-6 is one of its intermediates. There are several synthesis routes to manufacture this intermediate but some routes are protected by the patents in some countries. We strictly obey the laws and our commercial products are manufactured without infringing such patents. But anyway, the buyers should know the patent status by themselves. We promise to supply the real route of synthesis to the buyers. The buyers should take the risks of patent infringement by themselves.

Competitive Advantage: Produced under cGMP conditions, support customers’ registrations.